Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that the company plans to participate at the following conferences in February and March 2020:

9th Annual SVB Leerink Global Healthcare Conference
Date:                  Tuesday, February 25, 2020
Presentation time:3:30 p.m. ET
Location:             New York, New York
Webcast:             A live and archived webcast of the presentation will be available in the Events & Webcasts section of the Celyad website
 
3rd Annual CAR-TCR Summit Europe
Date:                  Wednesday, February 26, 2020
Time:                  12:30 p.m. GMT
Location:             London, United Kingdom 
 
27th International Molecular Med Tri-Conference
Date:                   Wednesday, March 4, 2020
Presentation Time:2:35 p.m. PT
Location:              San Francisco, California
 
Cambridge Healthtech Institute’s 5th Annual Immuno-Oncology Summit Europe 2020
Date:                   Wednesday, March 11, 2020
Presentation time: 9:05 a.m. GMT
Location:              London, United Kingdom 
 
BioCapital Europe 2020
Date:                   Thursday, March 12, 2020
Presentation time: 3:50 p.m. CET
Location:              Amsterdam, Netherlands   
 
VFB Congress Happening
Date:                   Saturday, March 28, 2020
Presentation time: 1:40 p.m. CET
Location:              Antwerp, Belgium

Download press release(s)

Press release

66.89 Ko

Communiqué de presse

108.16 Ko

Persbericht

67.30 Ko

Celyad Appoints Stephen Rubino as Chief Business Officer

Next News

Celyad Appoints Stephen Rubino as Chief Business Officer